nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Pain of skin—Bleomycin—testicular cancer	0.0533	0.0682	CcSEcCtD
Adapalene—Herpes labialis—Epirubicin—testicular cancer	0.0328	0.0419	CcSEcCtD
Adapalene—Herpes labialis—Doxorubicin—testicular cancer	0.0303	0.0388	CcSEcCtD
Adapalene—Papilloedema—Cisplatin—testicular cancer	0.0291	0.0373	CcSEcCtD
Adapalene—RXRA—female gonad—testicular cancer	0.0236	0.108	CbGeAlD
Adapalene—Dermatitis atopic—Chlorambucil—testicular cancer	0.0219	0.0281	CcSEcCtD
Adapalene—RARB—female gonad—testicular cancer	0.0212	0.0971	CbGeAlD
Adapalene—Oral herpes—Epirubicin—testicular cancer	0.0202	0.0258	CcSEcCtD
Adapalene—RARA—gonad—testicular cancer	0.02	0.0916	CbGeAlD
Adapalene—RXRB—female gonad—testicular cancer	0.0195	0.0892	CbGeAlD
Adapalene—Oral herpes—Doxorubicin—testicular cancer	0.0187	0.0239	CcSEcCtD
Adapalene—RXRG—testis—testicular cancer	0.0184	0.0841	CbGeAlD
Adapalene—RARG—female gonad—testicular cancer	0.0173	0.0792	CbGeAlD
Adapalene—RXRB—testis—testicular cancer	0.0173	0.0791	CbGeAlD
Adapalene—Sunburn—Methotrexate—testicular cancer	0.0168	0.0215	CcSEcCtD
Adapalene—RARA—female gonad—testicular cancer	0.0163	0.0744	CbGeAlD
Adapalene—RARG—testis—testicular cancer	0.0153	0.0702	CbGeAlD
Adapalene—Optic neuritis—Cisplatin—testicular cancer	0.0151	0.0193	CcSEcCtD
Adapalene—RARA—testis—testicular cancer	0.0144	0.066	CbGeAlD
Adapalene—Optic neuritis—Etoposide—testicular cancer	0.0138	0.0176	CcSEcCtD
Adapalene—RARB—lymph node—testicular cancer	0.0136	0.0624	CbGeAlD
Adapalene—Skin exfoliation—Bleomycin—testicular cancer	0.012	0.0154	CcSEcCtD
Adapalene—RARG—lymph node—testicular cancer	0.0111	0.0509	CbGeAlD
Adapalene—RARA—lymph node—testicular cancer	0.0104	0.0479	CbGeAlD
Adapalene—Skin exfoliation—Ifosfamide—testicular cancer	0.0103	0.0131	CcSEcCtD
Adapalene—Pain—Carboplatin—testicular cancer	0.00963	0.0123	CcSEcCtD
Adapalene—Skin discolouration—Etoposide—testicular cancer	0.00939	0.012	CcSEcCtD
Adapalene—Skin exfoliation—Cisplatin—testicular cancer	0.00884	0.0113	CcSEcCtD
Adapalene—Vesiculobullous rash—Epirubicin—testicular cancer	0.00848	0.0109	CcSEcCtD
Adapalene—Skin exfoliation—Etoposide—testicular cancer	0.0081	0.0104	CcSEcCtD
Adapalene—Vesiculobullous rash—Doxorubicin—testicular cancer	0.00785	0.01	CcSEcCtD
Adapalene—Optic neuritis—Epirubicin—testicular cancer	0.00773	0.00989	CcSEcCtD
Adapalene—Keratitis—Epirubicin—testicular cancer	0.00733	0.00938	CcSEcCtD
Adapalene—Burning sensation—Methotrexate—testicular cancer	0.00732	0.00936	CcSEcCtD
Adapalene—Optic neuritis—Doxorubicin—testicular cancer	0.00715	0.00915	CcSEcCtD
Adapalene—Redness—Epirubicin—testicular cancer	0.00705	0.00901	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Epirubicin—testicular cancer	0.00698	0.00893	CcSEcCtD
Adapalene—Burning sensation—Epirubicin—testicular cancer	0.00685	0.00876	CcSEcCtD
Adapalene—Keratitis—Doxorubicin—testicular cancer	0.00679	0.00868	CcSEcCtD
Adapalene—Redness—Doxorubicin—testicular cancer	0.00652	0.00834	CcSEcCtD
Adapalene—Face oedema—Cisplatin—testicular cancer	0.00649	0.0083	CcSEcCtD
Adapalene—Angioedema—Chlorambucil—testicular cancer	0.00649	0.0083	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Doxorubicin—testicular cancer	0.00646	0.00826	CcSEcCtD
Adapalene—Dermatitis atopic—Epirubicin—testicular cancer	0.00643	0.00822	CcSEcCtD
Adapalene—Burning sensation—Doxorubicin—testicular cancer	0.00633	0.0081	CcSEcCtD
Adapalene—Convulsion—Chlorambucil—testicular cancer	0.00615	0.00787	CcSEcCtD
Adapalene—Feeling hot—Epirubicin—testicular cancer	0.00606	0.00775	CcSEcCtD
Adapalene—Rash pustular—Epirubicin—testicular cancer	0.00596	0.00763	CcSEcCtD
Adapalene—Dermatitis atopic—Doxorubicin—testicular cancer	0.00595	0.00761	CcSEcCtD
Adapalene—Hepatitis—Dactinomycin—testicular cancer	0.00589	0.00753	CcSEcCtD
Adapalene—Stinging—Epirubicin—testicular cancer	0.00587	0.00751	CcSEcCtD
Adapalene—Conjunctivitis—Ifosfamide—testicular cancer	0.00584	0.00747	CcSEcCtD
Adapalene—Convulsion—Vinblastine—testicular cancer	0.00564	0.00721	CcSEcCtD
Adapalene—Skin discolouration—Methotrexate—testicular cancer	0.00563	0.0072	CcSEcCtD
Adapalene—Feeling hot—Doxorubicin—testicular cancer	0.00561	0.00717	CcSEcCtD
Adapalene—Rash pustular—Doxorubicin—testicular cancer	0.00552	0.00706	CcSEcCtD
Adapalene—Herpes simplex—Methotrexate—testicular cancer	0.00552	0.00706	CcSEcCtD
Adapalene—Erythema—Bleomycin—testicular cancer	0.0055	0.00703	CcSEcCtD
Adapalene—Stinging—Doxorubicin—testicular cancer	0.00543	0.00695	CcSEcCtD
Adapalene—Hepatitis—Ifosfamide—testicular cancer	0.0054	0.0069	CcSEcCtD
Adapalene—Skin discolouration—Epirubicin—testicular cancer	0.00527	0.00674	CcSEcCtD
Adapalene—Herpes simplex—Epirubicin—testicular cancer	0.00516	0.0066	CcSEcCtD
Adapalene—Erythema—Dactinomycin—testicular cancer	0.00513	0.00656	CcSEcCtD
Adapalene—Conjunctivitis—Cisplatin—testicular cancer	0.00504	0.00644	CcSEcCtD
Adapalene—Pain—Chlorambucil—testicular cancer	0.00496	0.00634	CcSEcCtD
Adapalene—Skin discolouration—Doxorubicin—testicular cancer	0.00487	0.00623	CcSEcCtD
Adapalene—Skin exfoliation—Methotrexate—testicular cancer	0.00485	0.00621	CcSEcCtD
Adapalene—Herpes simplex—Doxorubicin—testicular cancer	0.00478	0.00611	CcSEcCtD
Adapalene—Dermatitis contact—Epirubicin—testicular cancer	0.0047	0.00601	CcSEcCtD
Adapalene—Erythema—Ifosfamide—testicular cancer	0.0047	0.00601	CcSEcCtD
Adapalene—Urticaria—Chlorambucil—testicular cancer	0.0046	0.00589	CcSEcCtD
Adapalene—Pain—Vinblastine—testicular cancer	0.00454	0.00581	CcSEcCtD
Adapalene—Skin exfoliation—Epirubicin—testicular cancer	0.00454	0.00581	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—testicular cancer	0.00435	0.00556	CcSEcCtD
Adapalene—Angioedema—Ifosfamide—testicular cancer	0.00429	0.00549	CcSEcCtD
Adapalene—Hypersensitivity—Chlorambucil—testicular cancer	0.00427	0.00546	CcSEcCtD
Adapalene—Skin exfoliation—Doxorubicin—testicular cancer	0.0042	0.00538	CcSEcCtD
Adapalene—Pruritus—Chlorambucil—testicular cancer	0.0041	0.00524	CcSEcCtD
Adapalene—Convulsion—Ifosfamide—testicular cancer	0.00407	0.00521	CcSEcCtD
Adapalene—Erythema—Cisplatin—testicular cancer	0.00405	0.00518	CcSEcCtD
Adapalene—Hypersensitivity—Vinblastine—testicular cancer	0.00391	0.00501	CcSEcCtD
Adapalene—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00391	0.005	CcSEcCtD
Adapalene—Eczema—Epirubicin—testicular cancer	0.00384	0.00492	CcSEcCtD
Adapalene—Pain—Bleomycin—testicular cancer	0.00384	0.00491	CcSEcCtD
Adapalene—Eye pain—Epirubicin—testicular cancer	0.00382	0.00489	CcSEcCtD
Adapalene—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00366	0.00468	CcSEcCtD
Adapalene—Dermatitis bullous—Epirubicin—testicular cancer	0.00361	0.00462	CcSEcCtD
Adapalene—Pain—Dactinomycin—testicular cancer	0.00358	0.00458	CcSEcCtD
Adapalene—Urticaria—Bleomycin—testicular cancer	0.00356	0.00456	CcSEcCtD
Adapalene—Eczema—Doxorubicin—testicular cancer	0.00355	0.00455	CcSEcCtD
Adapalene—Eye pain—Doxorubicin—testicular cancer	0.00354	0.00453	CcSEcCtD
Adapalene—Convulsion—Cisplatin—testicular cancer	0.00351	0.00449	CcSEcCtD
Adapalene—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00339	0.00433	CcSEcCtD
Adapalene—Dermatitis bullous—Doxorubicin—testicular cancer	0.00334	0.00428	CcSEcCtD
Adapalene—Face oedema—Epirubicin—testicular cancer	0.00333	0.00426	CcSEcCtD
Adapalene—Hypersensitivity—Bleomycin—testicular cancer	0.0033	0.00423	CcSEcCtD
Adapalene—Pain—Ifosfamide—testicular cancer	0.00328	0.00419	CcSEcCtD
Adapalene—Convulsion—Etoposide—testicular cancer	0.00321	0.00411	CcSEcCtD
Adapalene—Pruritus—Bleomycin—testicular cancer	0.00317	0.00406	CcSEcCtD
Adapalene—Dry skin—Epirubicin—testicular cancer	0.00316	0.00405	CcSEcCtD
Adapalene—Face oedema—Doxorubicin—testicular cancer	0.00308	0.00395	CcSEcCtD
Adapalene—Hypersensitivity—Dactinomycin—testicular cancer	0.00308	0.00394	CcSEcCtD
Adapalene—Urticaria—Ifosfamide—testicular cancer	0.00305	0.0039	CcSEcCtD
Adapalene—Dry skin—Doxorubicin—testicular cancer	0.00293	0.00375	CcSEcCtD
Adapalene—Photosensitivity reaction—Methotrexate—testicular cancer	0.00291	0.00372	CcSEcCtD
Adapalene—Rash—Bleomycin—testicular cancer	0.00283	0.00362	CcSEcCtD
Adapalene—Pain—Cisplatin—testicular cancer	0.00283	0.00362	CcSEcCtD
Adapalene—Dermatitis—Bleomycin—testicular cancer	0.00283	0.00361	CcSEcCtD
Adapalene—Hypersensitivity—Ifosfamide—testicular cancer	0.00282	0.00361	CcSEcCtD
Adapalene—Conjunctivitis—Methotrexate—testicular cancer	0.00276	0.00354	CcSEcCtD
Adapalene—Photosensitivity reaction—Epirubicin—testicular cancer	0.00272	0.00348	CcSEcCtD
Adapalene—Pruritus—Ifosfamide—testicular cancer	0.00271	0.00347	CcSEcCtD
Adapalene—Rash—Dactinomycin—testicular cancer	0.00264	0.00337	CcSEcCtD
Adapalene—Pain—Etoposide—testicular cancer	0.00259	0.00331	CcSEcCtD
Adapalene—Conjunctivitis—Epirubicin—testicular cancer	0.00259	0.00331	CcSEcCtD
Adapalene—Hepatitis—Methotrexate—testicular cancer	0.00255	0.00327	CcSEcCtD
Adapalene—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00252	0.00322	CcSEcCtD
Adapalene—Hypersensitivity—Cisplatin—testicular cancer	0.00243	0.00311	CcSEcCtD
Adapalene—Rash—Ifosfamide—testicular cancer	0.00242	0.00309	CcSEcCtD
Adapalene—Dermatitis—Ifosfamide—testicular cancer	0.00241	0.00309	CcSEcCtD
Adapalene—Urticaria—Etoposide—testicular cancer	0.0024	0.00308	CcSEcCtD
Adapalene—Conjunctivitis—Doxorubicin—testicular cancer	0.00239	0.00306	CcSEcCtD
Adapalene—Hepatitis—Epirubicin—testicular cancer	0.00239	0.00306	CcSEcCtD
Adapalene—Hypersensitivity—Etoposide—testicular cancer	0.00223	0.00285	CcSEcCtD
Adapalene—Erythema—Methotrexate—testicular cancer	0.00222	0.00284	CcSEcCtD
Adapalene—Hepatitis—Doxorubicin—testicular cancer	0.00221	0.00283	CcSEcCtD
Adapalene—Pruritus—Etoposide—testicular cancer	0.00214	0.00274	CcSEcCtD
Adapalene—Rash—Cisplatin—testicular cancer	0.00208	0.00267	CcSEcCtD
Adapalene—Dermatitis—Cisplatin—testicular cancer	0.00208	0.00266	CcSEcCtD
Adapalene—Erythema—Epirubicin—testicular cancer	0.00208	0.00266	CcSEcCtD
Adapalene—Convulsion—Methotrexate—testicular cancer	0.00193	0.00246	CcSEcCtD
Adapalene—Erythema—Doxorubicin—testicular cancer	0.00192	0.00246	CcSEcCtD
Adapalene—Rash—Etoposide—testicular cancer	0.00191	0.00244	CcSEcCtD
Adapalene—Dermatitis—Etoposide—testicular cancer	0.00191	0.00244	CcSEcCtD
Adapalene—Convulsion—Epirubicin—testicular cancer	0.0018	0.0023	CcSEcCtD
Adapalene—Convulsion—Doxorubicin—testicular cancer	0.00167	0.00213	CcSEcCtD
Adapalene—Pain—Methotrexate—testicular cancer	0.00155	0.00198	CcSEcCtD
Adapalene—Pain—Epirubicin—testicular cancer	0.00145	0.00186	CcSEcCtD
Adapalene—Urticaria—Methotrexate—testicular cancer	0.00144	0.00184	CcSEcCtD
Adapalene—Urticaria—Epirubicin—testicular cancer	0.00135	0.00172	CcSEcCtD
Adapalene—Pain—Doxorubicin—testicular cancer	0.00134	0.00172	CcSEcCtD
Adapalene—Hypersensitivity—Methotrexate—testicular cancer	0.00134	0.00171	CcSEcCtD
Adapalene—Pruritus—Methotrexate—testicular cancer	0.00128	0.00164	CcSEcCtD
Adapalene—Hypersensitivity—Epirubicin—testicular cancer	0.00125	0.0016	CcSEcCtD
Adapalene—Urticaria—Doxorubicin—testicular cancer	0.00125	0.0016	CcSEcCtD
Adapalene—Pruritus—Epirubicin—testicular cancer	0.0012	0.00154	CcSEcCtD
Adapalene—Hypersensitivity—Doxorubicin—testicular cancer	0.00116	0.00148	CcSEcCtD
Adapalene—Rash—Methotrexate—testicular cancer	0.00114	0.00146	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—testicular cancer	0.00114	0.00146	CcSEcCtD
Adapalene—Pruritus—Doxorubicin—testicular cancer	0.00111	0.00142	CcSEcCtD
Adapalene—Rash—Epirubicin—testicular cancer	0.00107	0.00137	CcSEcCtD
Adapalene—Dermatitis—Epirubicin—testicular cancer	0.00107	0.00137	CcSEcCtD
Adapalene—Rash—Doxorubicin—testicular cancer	0.00099	0.00127	CcSEcCtD
Adapalene—Dermatitis—Doxorubicin—testicular cancer	0.000989	0.00127	CcSEcCtD
